QuPath: Open source software for digital pathology image analysis P Bankhead, MB Loughrey, JA Fernández, Y Dombrowski, DG McArt, ... Scientific reports 7 (1), 1-7, 2017 | 4734 | 2017 |
Digital pathology and image analysis in tissue biomarker research PW Hamilton, P Bankhead, Y Wang, R Hutchinson, D Kieran, DG McArt, ... Methods 70 (1), 59-73, 2014 | 229 | 2014 |
Challenging the cancer molecular stratification dogma: intratumoral heterogeneity undermines consensus molecular subtypes and potential diagnostic value in colorectal cancer PD Dunne, DG McArt, CA Bradley, PG O'Reilly, HL Barrett, R Cummins, ... Clinical Cancer Research 22 (16), 4095-4104, 2016 | 162 | 2016 |
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ... EBioMedicine 31, 182-189, 2018 | 138 | 2018 |
EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer PD Dunne, S Dasgupta, JK Blayney, DG McArt, KL Redmond, JA Weir, ... Clinical Cancer Research 22 (1), 230-242, 2016 | 133 | 2016 |
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis CM McCourt, DG McArt, K Mills, MA Catherwood, P Maxwell, DJ Waugh, ... PLoS One 8 (7), e69604, 2013 | 129 | 2013 |
AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer PD Dunne, DG McArt, JK Blayney, M Kalimutho, S Greer, T Wang, ... Clinical Cancer Research 20 (1), 164-175, 2014 | 115 | 2014 |
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer P Bankhead, JA Fernández, DG McArt, DP Boyle, G Li, MB Loughrey, ... Laboratory investigation 98 (1), 15-26, 2018 | 104 | 2018 |
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification PD Dunne, M Alderdice, PG O'Reilly, AC Roddy, AMB McCorry, ... Nature communications 8 (1), 15657, 2017 | 90 | 2017 |
QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017; 7: 16878 P Bankhead, MB Loughrey, JA Fernández, Y Dombrowski, DG McArt, ... CHAPTER, 2022 | 88 | 2022 |
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy S Jain, CA Lyons, SM Walker, S McQuaid, SO Hynes, DM Mitchell, ... Annals of Oncology 29 (1), 215-222, 2018 | 87 | 2018 |
Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer JS Riley, R Hutchinson, DG McArt, N Crawford, C Holohan, I Paul, ... Cell death & disease 4 (12), e951-e951, 2013 | 78 | 2013 |
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer DP Boyle, DG McArt, G Irwin, CS Wilhelm‐Benartzi, TF Lioe, E Sebastian, ... Histopathology 65 (3), 340-352, 2014 | 71 | 2014 |
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy WL Allen, PD Dunne, S McDade, E Scanlon, M Loughrey, HG Coleman, ... JCO precision oncology 2, 1-15, 2018 | 67 | 2018 |
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies M Alderdice, SD Richman, S Gollins, JP Stewart, C Hurt, R Adams, ... The Journal of pathology 245 (1), 19-28, 2018 | 65 | 2018 |
QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017; 7 (1): 16878 P Bankhead, MB Loughrey, JA Fernandez, Y Dombrowski, DG McArt, ... Journal for ImmunoTherapy of Cancer (JITC) preprint. The copyright holder …, 0 | 62 | |
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia SG Craig, MP Humphries, M Alderdice, V Bingham, SD Richman, ... British journal of cancer 123 (8), 1280-1288, 2020 | 61 | 2020 |
Automated tumor analysis for molecular profiling in lung cancer PW Hamilton, Y Wang, C Boyd, JA James, MB Loughrey, JP Hougton, ... Oncotarget 6 (29), 27938, 2015 | 61 | 2015 |
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer RA Hutchinson, RA Adams, DG McArt, M Salto-Tellez, B Jasani, ... Journal of translational medicine 13, 1-11, 2015 | 59 | 2015 |
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment NE Buckley, C Forde, DG McArt, DP Boyle, PB Mullan, JA James, ... Scientific reports 6 (1), 23383, 2016 | 58 | 2016 |